{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:33:50Z","timestamp":1778747630948,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11239-015-1230-6","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T03:41:31Z","timestamp":1431920491000},"page":"182-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sickle cell disease is associated with iron mediated hypercoagulability"],"prefix":"10.1007","volume":"40","author":[{"given":"Nirmish","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian J.","family":"Welsby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha A.","family":"Fielder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne K.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vance G.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"1230_CR1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.hoc.2013.11.011","volume":"28","author":"Z Pakbaz","year":"2014","unstructured":"Pakbaz Z, Wun T (2014) Role of the hemostatic system on sickle cell disease: pathophysiology and potential therapeutics. Hematol Oncol Clin N Am 28:355\u2013374","journal-title":"Hematol Oncol Clin N Am"},{"key":"1230_CR2","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.thromres.2012.08.307","volume":"130","author":"S Shah","year":"2012","unstructured":"Shah S, Thornburg C, Telen MJ, Ortel TL (2012) Characterization of the hypercoagulable state in patients with sickle cell disease. Thromb Res 130:e241\u2013e245","journal-title":"Thromb Res"},{"key":"1230_CR3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/asheducation-2013.1.447","volume":"2013","author":"J Porter","year":"2013","unstructured":"Porter J, Garbowski M (2013) Consequences and management of iron overload in sickle cell disease. Hematology Am Soc Hematol Educ Program 2013:447\u2013456","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1230_CR4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/MBC.0000000000000128","volume":"25","author":"VG Nielsen","year":"2014","unstructured":"Nielsen VG, Pretorius E (2014) Iron and carbon monoxide enhance coagulation and attenuate fibrinolysis by different mechanisms. Blood Coagul Fibrinolysis 25:695\u2013702","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1230_CR5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/MBC.0000000000000160","volume":"25","author":"VG Nielsen","year":"2014","unstructured":"Nielsen VG, Pretorius E (2014) Iron enhanced coagulation is attenuated by chelation: a thrombelastographic and ultrastructural analysis. Blood Coagul Fibrinolysis 25:845\u2013850","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1230_CR6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/MAT.0000000000000144","volume":"60","author":"RW Matika","year":"2014","unstructured":"Matika RW, Nielsen VG, Steinbrenner EB, Sussman AN, Madhrira M (2014) Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide. ASAIO J 60:716\u2013721","journal-title":"ASAIO J"},{"key":"1230_CR7","author":"KI Ataga","year":"2009","unstructured":"Ataga KI (2009) Novel therapies in sickle cell disease. Hematology Am Soc Hematol Educ Program. doi: 10.1182\/asheducation-2009.1.54","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1230_CR8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/088307380001500511","volume":"15","author":"RJ Adams","year":"2000","unstructured":"Adams RJ (2000) Lessons from the stroke prevention trial in sickle cell anemia (STOP) study. J Child Neurol 15:344\u2013349","journal-title":"J Child Neurol"},{"key":"1230_CR9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2141.2010.08451.x","volume":"152","author":"E Drasar","year":"2011","unstructured":"Drasar E, Igbineweka N, Vasavda N, Free M, Awogbade M, Allman M, Mijovic A, Thein SL (2011) Blood transfusion usage among adults with sickle cell disease\u2014a single institution experience over ten years. Br J Haematol 152:766\u2013770","journal-title":"Br J Haematol"},{"key":"1230_CR10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ajh.20685","volume":"81","author":"DS Darbari","year":"2006","unstructured":"Darbari DS, Kple-Faget P, Kwagyan J, Rana S, Gordeuk VR, Castro O (2006) Circumstances of death in adult sickle cell disease patients. Am J Hematol 81:858\u2013863","journal-title":"Am J Hematol"},{"key":"1230_CR11","doi-asserted-by":"crossref","first-page":"473152","DOI":"10.5402\/2011\/473152","volume":"2011","author":"PC Giordano","year":"2011","unstructured":"Giordano PC, Huisman W, Harteveld CL (2011) Iron depletion: an ameliorating factor for sickle cell disease? ISRN Hematol 2011:473152","journal-title":"ISRN Hematol"},{"key":"1230_CR12","first-page":"1","volume":"31","author":"L Jordan","year":"2014","unstructured":"Jordan L, Adams-Graves P, Kanter-Washko J, Oneal PA, Sasane M, Vekeman F, Bieri C, Magestro M, Marcellari A, Duh MS (2014) Multicenter COMPACT study of COMplications in patients with sickle cell disease and utilization of iron chelation therapy. Curr Med Res Opin 31:1\u201311","journal-title":"Curr Med Res Opin"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-015-1230-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1230-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:02:09Z","timestamp":1559372529000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-015-1230-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1230"],"URL":"https:\/\/doi.org\/10.1007\/s11239-015-1230-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725819849.793510060","asserted-by":"object"}]},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]}}}